2020 year
19 million people have cancer
More than 11 million died in a year
2024 year
28 million cases (forecast)
Pfizer Inc. has acquired from Aventis SA “Campto” for the treatment of cancer patients for $620 million.
Source
Development in the field of biotechnology, based on the isolation of melanin from a strain of black Antarctic yeast Nadsoniella nigra var. Hesuelica.
The development received positive feedback and support from the heads of three oncological centers in Russia, who rated it as a promising drug that reflects the latest methods in the treatment of tumor diseases.
19 million people have cancer
More than 11 million died in a year
28 million cases (forecast)
US National Library of Medicine National Institutes of Health 2017:
Pfizer Inc. has acquired from Aventis SA “Campto” for the treatment of cancer patients for $620 million.
GlaxoSmithKline plc has acquired “TESARO”, Waltham, Massachusetts-based oncology-focused company; the deal has been done for $5.1 billion.
The demand for health products is growing every year in the world. It is for those products that help to preserve youth and beauty. People no longer want to be mindlessly treated with chemical drugs, as they often do more harm than good.
Now we are on the verge of a very important event, we have fully mastered the tenology (active button) of the production of Alginar, and we are launching it into production. And you can join us on this path and contribute to the production of a product that brings health to people around the world.
Investments in a promising business with a turnover of more than $ 200 billion dollars a year
An opportunity to have access to all preparations and company developments at the lowest prices
The annual payment of dividends to investors of the company, after calculating the annual profit
The ability to transfer their shares in the company by inheritance
Participation in the creation of an important area in the safe therapy and treatment of many diseases
Profit from all development and investment tools of the company
In 2004 – preclinical trials.
In 2006 - 2007 – clinical trials of the first and second phase.
In 2015 – development of a suppository, a new formula of the drug named FRAN.
What is the difference between FRAN and existing drugs?
The common properties of all
chemotherapeutic drugs are high toxicity and a complete lack of selectivity of action, when the drug acts equally on
healthy cells of the body and on cancer cells.
The advantage of our project is the uniqueness of the drug. Unlike all other antitumor drugs, FRAN is an absolutely safe drug of natural origin and it does not contain chemical modifiers. This fact determines the unique therapeutic properties of the drug, which will create a very high demand for it in the future.
Research, as well as the opinion of practicing oncologists, suggests that the combination of positive properties makes it unique, without worthy competitors in the antitumor market. This is proved by preclinical trials, clinical trials and more than 500 people who have already been treated with FRAN.
By the sum of the positive qualities combining high antitumor efficacy, absolute selectivity towards tumor cells and complete absence of toxicity, the drug FRAN is unique in comparison with the well-known chemotherapeutic drugs.
The development of the drug FRAN is a revolutionary solution and it opens up a new direction in the science of creating drugs for the safe treatment of cancer and, which is important, it carries out prophylaxis to restore immunity in order to destroy cancer cells at an early stage.
Already, the drug can be ordered by contacting our representatives on our website ufgroup.pro
CloseYllo Messenger is a mobile application for instant messaging, crypto assets and business. Decentralized messenger built on cluster architecture. It does not have a central server. In addition to ordinary communication, it has a built-in crypto wallet for storing and transferring various cryptocurrencies
Crypto platform. On the Yllo platform you can issue any digital asset: with a unique name, logo and rules. The issuer himself sets the parameters of the total emission, inflation, burning, commission, distribution, initial price and any other properties of the asset.
Branding. Any element of the platform (instant messenger, notes, wallet for PC) can be branded as a client, as a personal tool based on Yllo.
Cryptocurrency exchange XLT.One - is a platform for the exchange of classic cryptocurrencies and all crypto assets created in Yllo.
Install the Yllo app for Apple
Close